Home
Conditions
Acquired Immunodeficiency Syndrome

Clinical trial condition

Acquired Immunodeficiency Syndrome

Explore clinical trials studying Acquired Immunodeficiency Syndrome. Study availability and eligibility vary by location and protocol.

2,558 public trials 178 recruiting studies

Refine in advanced search Browse all conditions

Acquired Immunodeficiency Syndrome trial results

Completed

Acceptability of Depo-subQ in Uniject

NCT01667276

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Ministry of Health Clinics All Cities Where There Is A Clinic, Senegal

Ministry of Health Clinics, Uganda All Cities Where There Is A Clinic, Uganda

View Trial Details

Completed

A Prospective Observational Study of the Clinical Performance of Femplant in Pakistan

NCT01463254

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Marie Stopes Society clinics Pakistan

View Trial Details

Completed

Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy

NCT01606722

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Hospital Universitarios Virgen del Rocio Seville, Spain

View Trial Details

Completed

Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients

NCT00672932

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Ucsf Ccrc, Sfgh San Francisco, California, United States

View Trial Details

Completed

A Prospective Observational Study of the Performance of Zarin in Kenya

NCT01334190

Conditions: Acquired Immunodeficiency Syndrome, Behavior, Blood-Borne Infections, +17 more
Locations: FHI Nairobi, Nairobi County, Kenya

View Trial Details

Completed

Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection

NCT01751555

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: National Center for AIDS/STD Control and Prevention, China CDC Beijing, Beijing Municipality, China

View Trial Details

Completed

A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients

NCT01391013

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study

NCT00128830

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients

NCT00838162

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Berlin, Germany

Frankfurt, Germany

Hamburg, Germany

View Trial Details

Completed

Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS

NCT00963235

Conditions: Acquired Immunodeficiency Syndrome, Bacterial Infections, Bacterial Infections and Mycoses, +18 more
Locations: Pfizer Investigational Site San Francisco, California, United States

Pfizer Investigational Site Aurora, Colorado, United States

Pfizer Investigational Site Washington D.C., District of Columbia, United States

Pfizer Investigational Site Lexington, Kentucky, United States

View all 15 locations

View Trial Details

Acquired Immunodeficiency Syndrome

Acquired Immunodeficiency Syndrome trial results

Related conditions